TY - JOUR
T1 - Prioritising Urological Surgery in the COVID-19 Era
T2 - A Global Reflection on Guidelines
AU - Gravas, Stavros
AU - Fournier, Georges
AU - Oya, Mototsugu
AU - Summerton, Duncan
AU - Scarpa, Roberto Mario
AU - Chlosta, Piotr
AU - Gkialas, Ioannis
AU - Xie, Li Ping
AU - Rasyid, Nur
AU - Bolton, Damien
AU - Gomez, Reynaldo
AU - Klotz, Laurence
AU - Kulkarni, Sanjay
AU - Tanguay, Simon
AU - de la Rosette, Jean
N1 - Publisher Copyright:
© 2020 European Association of Urology
PY - 2020/9/15
Y1 - 2020/9/15
N2 - Background: Determining whether members follow guidelines, including guidelines prepared to help direct practice management during the coronavirus disease 2019 (COVID-19) pandemic, is an important goal for medical associations. Objective: To determine whether practice of urologists is in line with guidelines for the management of common urological conditions during the COVID-19 pandemic produced by leading (inter)national urological associations. Design, setting, and participants: Self-selected urologists completed a voluntary survey available online from March 27 to April 11, 2020 and distributed globally by the Société Internationale d'Urologie. Outcome measurements and statistical analysis: Responses to two survey questions on the (1) management of 14 common urological procedures and (2) priority scoring of 10 common urological procedures were evaluated by practice setting and geographical region using chi-square and one-way analysis of variance analyses, respectively. Results and limitations: There were 2494 respondents from 76 countries. Oncological conditions were prioritised over benign conditions, and benign conditions were deferred when feasible and safe. Oncological conditions with the greatest malignant potential were prioritised over less aggressive cancers. Respondents from Europe were least likely to postpone and most likely to prioritise conditions identified by guidelines as being of the highest priority. Respondents’ priority scoring of urological procedures closely matched the priorities assigned by guidelines. The main limitation of this study is that respondents were self-selected, and access to the survey was limited by language and technology barriers. Conclusions: Prioritisation and management of urological procedures during the COVID-19 pandemic are in line with current guidelines. The greatest agreement was reported in Europe. Observed differences may be related to limited resources in some settings. Patient summary: When deciding how best to treat patients during the coronavirus disease 2019 (COVID-19) pandemic, urologists are taking into account both expert recommendations and the availability of important local resources. Urologists worldwide have a high level of knowledge of coronavirus disease 2019 (COVID-19) guidelines for the management of urological conditions during the pandemic but may need to adapt their practices based on regional resource availability.
AB - Background: Determining whether members follow guidelines, including guidelines prepared to help direct practice management during the coronavirus disease 2019 (COVID-19) pandemic, is an important goal for medical associations. Objective: To determine whether practice of urologists is in line with guidelines for the management of common urological conditions during the COVID-19 pandemic produced by leading (inter)national urological associations. Design, setting, and participants: Self-selected urologists completed a voluntary survey available online from March 27 to April 11, 2020 and distributed globally by the Société Internationale d'Urologie. Outcome measurements and statistical analysis: Responses to two survey questions on the (1) management of 14 common urological procedures and (2) priority scoring of 10 common urological procedures were evaluated by practice setting and geographical region using chi-square and one-way analysis of variance analyses, respectively. Results and limitations: There were 2494 respondents from 76 countries. Oncological conditions were prioritised over benign conditions, and benign conditions were deferred when feasible and safe. Oncological conditions with the greatest malignant potential were prioritised over less aggressive cancers. Respondents from Europe were least likely to postpone and most likely to prioritise conditions identified by guidelines as being of the highest priority. Respondents’ priority scoring of urological procedures closely matched the priorities assigned by guidelines. The main limitation of this study is that respondents were self-selected, and access to the survey was limited by language and technology barriers. Conclusions: Prioritisation and management of urological procedures during the COVID-19 pandemic are in line with current guidelines. The greatest agreement was reported in Europe. Observed differences may be related to limited resources in some settings. Patient summary: When deciding how best to treat patients during the coronavirus disease 2019 (COVID-19) pandemic, urologists are taking into account both expert recommendations and the availability of important local resources. Urologists worldwide have a high level of knowledge of coronavirus disease 2019 (COVID-19) guidelines for the management of urological conditions during the pandemic but may need to adapt their practices based on regional resource availability.
KW - COVID-19
KW - Coronavirus
KW - Guidelines
KW - Pandemic
KW - Practice management
KW - Severe acute respiratory syndrome coronavirus 2
KW - Urology
UR - http://www.scopus.com/inward/record.url?scp=85086661571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086661571&partnerID=8YFLogxK
U2 - 10.1016/j.euf.2020.06.006
DO - 10.1016/j.euf.2020.06.006
M3 - Article
C2 - 32571743
AN - SCOPUS:85086661571
SN - 2405-4569
VL - 6
SP - 1104
EP - 1110
JO - European Urology Focus
JF - European Urology Focus
IS - 5
ER -